Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

NEK9

RBC: NEK9 · Substrate: MBP · high confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Fostamatinib100.00.61
Dabrafenib99.70.63
Pacritinib78.70.45
Axitinib76.50.69
Crizotinib72.10.58
Brigatinib70.70.51
Fedratinib61.30.58
Midostaurin59.90.50
Defactinib59.00.45
Avapritinib51.20.64
Vemurafenib45.80.60
Ripretinib41.50.67
Ponatinib36.90.53
Sorafenib26.90.78
Pralsetinib25.40.64

Known variants

No variants catalogued.
Open in new tab